Spartan Delta Corp. (TSE:SDE – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is C$5.50.
Several brokerages have recently weighed in on SDE. Cormark upgraded Spartan Delta to a “strong-buy” rating in a report on Monday, September 23rd. National Bankshares reduced their target price on Spartan Delta from C$6.00 to C$5.50 in a research note on Friday, September 27th. Finally, BMO Capital Markets lowered their target price on shares of Spartan Delta from C$6.00 to C$5.00 in a research note on Friday.
View Our Latest Report on Spartan Delta
Spartan Delta Trading Down 2.2 %
Spartan Delta (TSE:SDE – Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported C$0.02 earnings per share for the quarter. The company had revenue of C$60.55 million for the quarter. Spartan Delta had a net margin of 50.10% and a return on equity of 37.82%. As a group, analysts expect that Spartan Delta will post 0.305004 EPS for the current year.
About Spartan Delta
Spartan Delta Corp. engages in the exploration, development, and production of oil and natural gas reserves in the Western Canada. Its assets are located in Montney and Deep Basin. The company was formerly known as Return Energy Inc and changed its name to Spartan Delta Corp. in May 2020. The company was incorporated in 2006 and is headquartered in Calgary, Canada.
Recommended Stories
- Five stocks we like better than Spartan Delta
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How is Compound Interest Calculated?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Bond Market Holiday? How to Invest and Trade
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Spartan Delta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spartan Delta and related companies with MarketBeat.com's FREE daily email newsletter.